Brief: VBI Vaccines Inc - $82.4 Million In Cash At End Of Q2 2022

VBI Vaccines

08/08/2022 13:22

Aug 8 (Reuters) - VBI Vaccines Inc  VBIV.O :
    * VBI VACCINES REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
    * VBI VACCINES INC - $82.4 MILLION IN CASH AT END OF Q2 2022
    * VBI VACCINES INC - NET LOSS AND NET LOSS PER SHARE FOR Q2
OF
2022 WERE $45.7 MILLION AND $0.18, RESPECTIVELY
    * VBI VACCINES INC - NET LOSS AND NET LOSS PER SHARE,
EXCLUDING
FOREIGN EXCHANGE LOSS, FOR Q2 OF 2022 WERE $23.8 MILLION AND
$0.09, RESPECTIVELY

Source text for Eikon:  ID:nBw9kNvMTa 
Further company coverage:  VBIV.O 

 ((Reuters.Briefs@thomsonreuters.com;))